HC Surgical Specialists Limited (SGX:1B1)

Market Cap	50.61M
Revenue (ttm)	19.19M
Net Income (ttm)	8.44M
Shares Out	153.38M
EPS (ttm)	0.05
PE Ratio	6.01
Forward PE	n/a
Dividend	0.02 (7.15%)
Ex-Dividend Date	Feb 28, 2025

Volume	51,600
Average Volume	85,520
Open	0.3350
Previous Close	0.3350
Day's Range	0.3300 - 0.3350
52-Week Range	0.2400 - 0.3550
Beta	0.04
RSI	58.46
Earnings Date	Jul 25, 2025

About HC Surgical Specialists

HC Surgical Specialists Limited, an investment holding company, provides medical services primarily in Singapore. The company provides endoscopic procedures, including gastroscopies and colonoscopies; and general surgery services with a focus on colorectal procedures in a network of clinics. It also offers treatment services for other conditions, such as haemorrhoids, anal fissure, hernia, anal abscess, cholecystitis, anal fistula, appendicitis, colorectal cancer, lipomas, cysts, and gastric cancer, vein laser vascular, laparoscopy, and other g...

• Industry: Offices and Clinics of Doctors of Medicine
• Founded: 2015
• Country: Singapore
• Stock Exchange: Singapore Exchange - Catalist
• Ticker Symbol: 1B1

Financial Performance

In 2025, HC Surgical Specialists's revenue was 19.19 million, an increase of 0.71% compared to the previous year's 19.05 million. Earnings were 8.44 million, an increase of 119.42%.